Leg raise test may predict acid reflux risk in obese patients before weight-loss surgery
NCT ID NCT06222177
First seen Jul 17, 2026 ยท Last updated Jul 17, 2026
Summary
This study aims to define normal pressure thresholds during a straight leg raise maneuver in high-resolution manometry to predict acid reflux in obese patients. Researchers will analyze data from 150 obese patients undergoing preoperative assessment for bariatric surgery. The goal is to establish a cutoff value that can identify patients at risk of developing gastroesophageal reflux disease after sleeve gastrectomy.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a reliable test to predict which obese patients are at risk of acid reflux after sleeve gastrectomy, helping surgeons choose the best procedure.
- What could go wrong
- This is an observational study to define normal values, not a treatment trial. The thresholds found may not apply to all patients or may not accurately predict reflux in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRO ESOPHAGEAL REFLUX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IRCCS Policlinico San Donato
San Donato Milanese, Milan, 20097, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- Three quick endoscopic checks may predict who still has reflux after surgery
- A daily pill for obesity? zenagamtide faces its biggest test yet.